| References |
Top |
| REF 1 |
The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92.
|
| REF 2 |
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One. 2008 Sep 4;3(9):e3135.
|
| REF 3 |
Partial regulation of serotonin transporter function by gamma-synuclein. Neurosci Lett. 2009 Apr 10;453(3):157-61.
|
| REF 4 |
Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett. 2003 Apr 17;340(3):189-92.
|
| REF 5 |
Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions. Eur J Neurosci. 2005 Jan;21(2):317-26.
|
| REF 6 |
Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem. 2009 Oct 2;284(40):27252-64.
|
| REF 7 |
Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation. Exp Cell Res. 2005 Aug 1;308(1):78-84.
|
| REF 8 |
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics. 2008 Nov;7(11):2123-37.
|
| REF 9 |
Phosphorylation of -synuclein is crucial in compensating for proteasomal dysfunction. Biochem Biophys Res Commun. 2012 Aug 3;424(3):597-603.
|
| REF 10 |
Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy. J Biol Chem. 2007 Nov 23;282(47):34555-67.
|
